This is a preview of subscription content, log in via an institution to check access.
Notes
The study was funded by Bayer AG, Basel, Switzerland.
Early Treatment Diabetic Retinopathy Study
Reference
Carrasco J, et al. Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies. Advances in Therapy : 14 Nov 2019. Available from: URL: http://doi.org/10.1007/s12325-019-01147-6
Rights and permissions
About this article
Cite this article
Aflibercept in neovascular AMD: better outcomes, acceptable cost. PharmacoEcon Outcomes News 842, 4 (2019). https://doi.org/10.1007/s40274-019-6396-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6396-2